- Entry
- $16.30
- Final
- $32.70 +100.6%
- Target
- —
- Score
- -1.00
I started looking at this after the Novo suit dropped and kept pulling threads. Figured I’d post the risk map because the bull and bear takes I keep seeing here miss the same thing. People argue HIMS like it’s one company. It’s two. Business A is the cash pay subscription platform: hair, ED, derm, mental health. Recurring revenue, no insurance friction. That engine is real and I’m not here to dunk on it. Business B was the GLP1 compounding era. …
— ORIGINAL POST ·
HIMS: Risk map (88% control lockout, GLP-1 exposure, and the 2030 convert clock)
· r/stocks
· Feb 13, 2026